In focus: Aim Lab Automation Technologies
This month we spoke with David McGrath, Project Manager at Aim Lab Automation Technologies, about his experience in our program.
Why did you join the LSI Export Hub, and what has your experience been so far?
“We joined the hub in November last year with a view to developing new partnerships and market knowledge. Our experience so far has offered the opportunity to collaborate with other SME’s, and we continue to improve under the tutelage of the hub’s mentors.
The ability to connect virtually throughout the pandemic with market experts, especially those that are on the ground in other countries, has given us great insight as we look to diversify into new markets.”
What do you hope to achieve through the hub’s network?
“As the biomedical industry becomes a priority industry for Queensland, we are keen to work with SME’s to plan, build and deploy their ideas. We have a competitive advantage with ISO13485 certification, which means we design, manufacture and maintain products at the highest, internationally-recognised standard of quality.”
You can learn more and connect with the team through the Aim Lab Automation Technologies website.
Who is taking part in our program?
A selection of our current participants include:
Aim Lab Automation Technologies
Aim Lab Automation Technologies
is an award-winning product design, engineering and manufacturing company with over 40 years’ experience in developing innovative robotic instrumentation and modules for the biotechnology industry. Aim Lab has partnered with many of the world’s largest diagnostics companies to transform concepts and prototypes from good ideas into quality manufactured products.
Aim Lab has the unique, competitive advantage of being ISO13485 certified, so you can be confident that the design, production, installation and servicing of your medical devices and related services meet the highest, internationally-recognised quality standards.
is a technology-focused international marketing consultancy that works with Australian technology and innovation SME’s to create, coordinate and capture opportunities in Asia. Their proprietary, full-stack solution systems, service processes and capabilities support strategic initiatives and operations for Asia. They offer personalised services and bespoke solutions for strategy, communications management, and partnership development.
Body Fat Predictive Framework
Accurately predicting percentage of body fat can be extremely challenging. Current measuring systems are expensive (approx. $8,000 USD each) and current medical software must take many body measurements into consideration. Dr Farshid Keivanian proposes a novel framework with smartphone app integration that measures fat deposits across different parts of the body, with a more accurate and reliable tracking system that requires fewer individual measurements than the current artificial intelligence models and body mass index (BMI). Using the framework could result in more cost effective and faster prevention of heart problems, through an app that can be used by doctors and patients. See Dr Farshid Keivanian's website
for more information.
are registered R&D tax agents advising and assisting local and global technology organisations, accelerator programs and incubators to access Australian R&D tax offsets. Clearpoint Ventures are currently working with a range of clients, from start-ups based at universities including Swinburne, La Trobe, and RMIT - through to global partner organisations. Their services include complimentary, no-obligation guidance on R&D Tax Incentives and other funding sources.
DMM Biomedical Consulting
DMM Biomedical Consulting offer a novel Quality by Design (QbD) system for patient-specific medical devices. Following the QbD system results in FDA-compliant medical products that are correctly designed from the start, with reduced waste, time and cost through early detection of errors.
Currently the novel QbD system has been implemented at Griffith University to develop 3D printed, single use, patient-specific surgical guides for high surgical accuracy and increased post-operative range of motion and muscle function. It helps to prevent surgical complications including nerve and blood vessel damage, and allows to reduce radiation dose, surgery time and costs. Email email@example.com
for more information.
, Australia’s leading provider of commercial chemistry services, has exclusive rights to a novel, disruptive and innovative technology called Oxidative Hydrothermal Dissolution (OHD), used for converting organic feedstocks to high-value end user products. Epichem has a licence agreement to apply the technology in countries across Australasia, to recycle chemicals into valuable resources for the mining, recycling, renewables, agriculture, energy, pharmaceutical, waste, textile and resources industries.
Concussion and traumatic brain injury impacts millions of people yearly worldwide and minute-to-minute in emergency departments. Along with sports injury, it is also the leading cause of morbidity in the military.
is using clinical trials to validate biomarkers for the diagnosis and prognosis of traumatic brain injury and concussion. Working with medical and scientific experts worldwide, they have developed a point-of-care platform that assists with triage, patient treatment and recovery programs. GLIA is also working with the ADF and US DoD to fast track the technology and its uptake by operators across sports, emergency departments and the military.
Healthcare services in the developed world are suffering from profit-driven approaches. As an alternative, IdeaMed
offers a data-driven, self-guided approach based on principles of participatory medicine, as applied to sustainable healthcare services.
is an Australian food company developing healthy and delicious cultured meat products (also known as lab-grown or cell-based meat). Magic Valley’s products will help to reduce negative environmental impacts, remove animals from the supply chain, provide a sustainable and accessible protein source and reduce food waste, as well as being less prone to biological risk and disease than traditional meat products.
is developing technology for at-home cardio therapy and stroke rehabilitation with online telehealth integration. The technology is based on connected rehabilitation devices for legs that can be used at care facilities and at home. The devices are used in conjunction with telerehabilitation programs and self-managed training. MDXD products respond to emerging markets of digital chronic disease management and rehabilitation of the elderly in Asia.
Dr Padma Murthi, Monash University
Dr Padma Murthi
is a reproductive biologist and placentologist focusing on pregnancy disorder detection and treatment. She has identified a protein in the human placenta called the formyl peptide receptor (FPR2), which has the same anti-inflammatory property found in diseases including cancer. With funding from Ferring Pharmaceuticals (USA) she developed FPR2 as a diagnostic tool, and is developing its agonist to be used as a diagnostic marker and therapeutic target to improve pregnancy outcomes for women who experience pregnancy disorders including foetal growth restriction and preeclampsia.
Currently, two in three commonly prescribed medicines are ineffective for patients for the intended treatment aim. Standard clinical trials are designed to determine if a treatment works for a group, but not usually for each patient in the trial, and can be costly and time consuming.
offer personalised clinical trials for testing individual responses to a treatment, that can be pooled to give group results like a standard clinical trial, but more quickly and cost effectively.
N-of-1 Hub designs, implements and analyses trials, and trains and supports the clinical trials sector in the method. They are enabling a future of personalised medical treatment, where patients are confident they are receiving treatment that works specifically for them.
NeuroCo is an early-stage digital health company with the purpose to empower individuals to manage their mental health. They are developing an evidence-based, personalised and scalable digital mental health platform and products to control psychiatric disorders. NeuroCo products connect devices and assimilate information from multi-sensory signals to assess mental health. Email Dr Namunu Maddage
for more information.
provides a virtual reality-based enrichment experience and communication solution to aged care and retirement communities. SilVR Adventures offer group virtual reality activities that help to reduce isolation and drive social engagement. Residents can chat, travel the world and even watch a classic movie with other residents, all in a virtual world.